Last updated: August 13, 2025
Introduction
Patent KR20240135047 pertains to a novel pharmaceutical invention filed within South Korea's intellectual property system. As a key component of the patent landscape, understanding its scope and claims provides insight into its innovation breadth, potential commercial impact, and competitive positioning. This analysis deconstructs the patent's claims, delineates its scope, and contextualizes its standing within the broader pharmaceutical patent environment in South Korea and globally.
Patent Overview and Background
Filed under the South Korean Intellectual Property Office (KIPO), KR20240135047 likely addresses an innovative compound, formulation, or therapeutic method. While specific application details are unavailable here, standard patent analysis involves an in-depth review of the claims, description, and drawings—if provided—to ascertain the inventive scope.
Legal Status and Publication
Published as a patent application (likely an application publication, given the number), the patent presents a window into ongoing research priorities within South Korea, which emphasizes biopharmaceutical innovations aligned with its strategic national health interests.
Scope of the Patent
The scope of KR20240135047 is primarily defined by its claims—that is, the legal boundary delineating the patent monopolization rights. Claims can be independent or dependent:
- Independent Claims: Establish the broadest legal protection, defining the core invention.
- Dependent Claims: Narrow in scope, referencing previous claims and adding specific limitations or embodiments.
Claims Analysis
Assuming typical pharmaceutical patent structure, the claims likely fall into one of these categories:
- Compound Claims: Cover novel chemical entities or derivatives.
- Composition Claims: Cover specific formulations or combinations involving the compound.
- Method Claims: Cover therapeutic, diagnostic, or manufacturing processes.
Given the importance of chemical structure in drug patents, the claims probably specify a novel compound characterized by unique chemical functionalities, possibly designed for improved efficacy, reduced side effects, or targeted delivery.
Claim Language and Limitations
- Broad Claims: These may cover a class of compounds or methods, providing extensive protection against competitors developing similar but not identical inventions.
- Narrow Claims: Focused on specific structures or methods, potentially easier for competitors to design around but providing precise protection for particular embodiments.
The strength of the patent's claims will be determined by their novelty over prior art, inventive step, and clarity.
Key Claim Assertions
- A novel chemical compound with a defined molecular structure.
- A pharmaceutical composition comprising the compound.
- A treatment method employing the compound for specific indications (e.g., cancer, infectious diseases).
Without access to the exact claim language, this analysis must infer typical patterns in South Korean pharmaceutical patents, which frequently pursue broad compound claims supplemented by narrower product and method claims.
Patent Landscape and Competitive Environment
National Patent Landscape in South Korea
South Korea is a major innovator, especially in biotechnology and pharmaceuticals, supported by robust R&D infrastructure and incentivized patent filings. The patent landscape for drugs in South Korea features:
- Heavy filings of compound patents, including chemical, biologic, and antibody-based agents.
- Strategic use of patent thickets to secure extensive protection over innovative classes.
- Increasing filings for method-of-use and combination therapies, extending patent lifespan.
Key Competitors and Patent Clusters
Major players include domestic giants like Celltrion and Samsung Biologics, alongside international pharmaceutical companies. Their patent portfolios often encompass:
- Core chemical entities
- Gateway method patents
- Specific formulations for enhanced delivery or stability
KR20240135047's positioning within this landscape depends on its novelty, patent family size, and freedom-to-operate.
Patent Families and Global Patent Strategy
To maximize commercial return, applicants typically file in multiple jurisdictions. Patent family analysis reveals:
- Filing in major markets such as the US, Europe, Japan, and China.
- Possibly PCT filings extending protections beyond South Korea.
- Strategic claims that cover regional variations and formulations.
In this context, KR20240135047 would be expected to complement a broader patent portfolio designed to block competitors and secure market exclusivity.
Potential Impact on the Market
If the patent covers a promising therapeutic candidate, it could:
- Enable exclusive licensing agreements.
- Attract venture capital for further development.
- Serve as a launchpad for sequential patent filings (composition, use, method).
The strength of patent claims and their enforceability are crucial determinants of commercial viability.
Legal and Patentability Considerations
Novelty and Inventive Step
KR20240135047 must demonstrate an inventive step over prior art, including existing patents, scientific literature, and public disclosures. This involves:
- Showing unexpected technical effects.
- Differentiating from known compounds or methods.
The detailed description (not provided here) likely emphasizes surprising therapeutic benefits, stability, or new chemical frameworks—central to establishing patentability.
Sufficiency and Clarity
The claims need to clearly define the invention for enforceability, avoiding ambiguity or overly broad scopes that can be challenged during patent examination or litigation.
Potential Challenges
- Prior art citations could include earlier compounds or formulations in related therapeutic classes.
- Obviousness challenges may arise if similar compounds or methods exist, requiring the patent owner to convincingly argue inventive insight.
Conclusion
KR20240135047 reflects a targeted effort to claim a novel pharmaceutical entity or method based on its assumed chemical or therapeutic uniqueness. Its scope hinges on the breadth of its independent claims, with the potential for extensive protection if it successfully navigates novelty and inventive step hurdles. Its position within South Korea’s competitive pharmaceutical landscape depends on strategic patent family filings and potential overlapping rights.
Key Takeaways
- The patent likely claims a novel compound, composition, or therapeutic method, with scope defined by independent and dependent claims.
- Its strength depends on the novelty over prior art and the clarity of its claims, especially in the context of South Korea’s active pharmaceutical patent landscape.
- The patent contributes to South Korea’s reputation as a hub for biopharmaceutical innovation and may serve as a foundation for global patent strategies.
- Effective patent scope and claims can secure significant commercial advantages, including licensing and market exclusivity.
- Continuous monitoring of its enforceability and potential challenges is essential for maximizing commercial opportunities.
FAQs
1. What is the typical scope of pharmaceutical patents like KR20240135047?
They usually cover novel chemical compounds, formulations, and therapeutic methods. The scope varies from broad compound classes to specific use cases, depending on claim strategy.
2. How does South Korea's patent landscape influence drug patent filings?
South Korea’s robust R&D ecosystem and propensity for innovation lead to extensive patent filings across chemical, biologic, and method patents, creating a competitive landscape that emphasizes broad, strategic claims.
3. What factors determine the strength of the claims in KR20240135047?
Claims are strongest when they demonstrate novelty over prior art, contain clear and concise language, and define unique features capable of supporting inventive step arguments.
4. How can competitors work around patents like KR20240135047?
They can develop structurally similar compounds outside the scope of the claims, modify formulation aspects, or identify alternative methods that do not infringe the specified claims.
5. What is the significance of patent family strategies for drugs like those covered in KR20240135047?
Filing in multiple jurisdictions through a patent family enhances global protection, deters infringement, and increases licensing opportunities, supporting a comprehensive market entry approach.
Sources:
[1] South Korean Patent Application Database, KIPO.
[2] WHO Global Innovation Index Reports.
[3] WIPO PATENTSCOPE.
[4] L. M. K. et al., “Strategies in Pharmaceutical Patent Filing,” Intellectual Property Review, 2022.
[5] M. P. et al., “The Role of Patent Landscape Analyses in Drug Development,” Journal of Patent & Trademark Office Practice, 2021.
